GO:0095500 acetylcholine receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0095500 acetylcholine receptor signaling pathway describes the molecular signals triggered when an acetylcholine receptor binds a physiological ligand such as acetylcholine or nicotine.
• The pathway includes both nicotinic (ionotropic) and muscarinic (metabotropic) acetylcholine receptors, which differ in structure, ion permeability and downstream effectors.
• Key signaling arms include α7nAChR-JAK2/STAT3 in inflammation, AKT-dependent regulation of receptor surface density, and muscarinic modulation of vascular tone.
• The pathway is conserved from invertebrates to humans; levamisole-sensitive acetylcholine receptors regulate short-term forgetting in Caenorhabditis elegans.
• Dysregulation of acetylcholine receptor signaling is linked to lung cancer, metabolic dysfunction-associated steatohepatitis, and cholinergic anti-inflammatory disorders.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of receptor subunits and downstream signaling nodes.
Description
The acetylcholine receptor signaling pathway (GO:0095500) is the series of molecular events initiated when an acetylcholine receptor binds one of its physiological ligands. Acetylcholine receptors are divided into two major classes: nicotinic acetylcholine receptors (nAChRs), which are ligand-gated ion channels, and muscarinic acetylcholine receptors (mAChRs), which are G-protein-coupled receptors. This pathway is essential for fast synaptic transmission at the neuromuscular junction, autonomic ganglia, and within the central nervous system, and it also mediates slower neuromodulatory and anti-inflammatory effects. Because the pathway controls ion flux, kinase cascades and gene expression, it is a central node in physiology and disease. Researchers study GO:0095500 to understand how cholinergic signals regulate inflammation, metabolism, vascular tone, memory and cancer biology. The pathway is also a major pharmacological target: nicotinic and muscarinic agonists and antagonists are used clinically, and receptor subunit genes are frequent subjects of genetic manipulation. In this article we summarize the definition, mechanism, key genes, disease links and research methods for GO:0095500, with all factual statements supported by verified PubMed citations.
acetylcholine receptor signaling pathway At A Glance
| GO ID | GO:0095500 |
|---|---|
| GO term | acetylcholine receptor signaling pathway |
| Ontology | biological_process |
| Synonym | acetylcholine receptor signalling pathway |
| Definition | The series of molecular signals generated as a consequence of an acetylcholine receptor binding to one of its physiological ligands. |
| Major function | Transduces acetylcholine or nicotine binding into ion flux, G-protein activation and downstream kinase signaling. |
| Receptor classes | Nicotinic (ionotropic) and muscarinic (metabotropic) acetylcholine receptors. |
| Representative downstream nodes | JAK2/STAT3, AKT, α1-adrenergic vasoconstriction modulation. |
| Conservation | Present in vertebrates and invertebrates, including C. elegans levamisole-sensitive receptors. |
What Is GO:0095500?
GO:0095500 acetylcholine receptor signaling pathway is defined as the series of molecular signals generated as a consequence of an acetylcholine receptor binding to one of its physiological ligands. In practice, this means that when acetylcholine, nicotine or another physiological agonist occupies the ligand-binding domain of a nicotinic or muscarinic receptor, the receptor changes conformation and initiates downstream signaling. For nicotinic receptors, ligand binding opens a cation-selective pore, allowing Na+, K+ and Ca2+ flux that depolarizes the membrane and can activate voltage-gated channels and calcium-dependent enzymes. For muscarinic receptors, ligand binding activates heterotrimeric G proteins that modulate adenylyl cyclase, phospholipase C and ion channels. The term therefore covers receptor activation, immediate ion flux or G-protein coupling, and the subsequent intracellular cascades that alter cell behavior.
Why Is acetylcholine receptor signaling pathway Important in Cell Biology?
GO:0095500 is important because acetylcholine receptor signaling coordinates fundamental processes ranging from neuromuscular transmission and autonomic control to inflammation, metabolism and cognition. The pathway is also a validated drug target: nicotinic and muscarinic ligands are used in anesthesia, neurology and gastroenterology, and receptor subunits are implicated in lung cancer and metabolic liver disease. Understanding the precise molecular steps of this pathway helps researchers design selective modulators and interpret genetic variants that alter receptor function.
• Controls fast synaptic transmission at the neuromuscular junction and autonomic ganglia through nicotinic receptors.
• Mediates cholinergic anti-inflammatory signaling via α7nAChR and RIC-3.
• Regulates intestinal inflammation through α7nAChR-mediated JAK2/STAT3 signaling in postoperative ileus.
• Modulates vascular tone by blunting α1-adrenergic vasoconstriction during exercise.
• Protects against metabolic dysfunction-associated steatohepatitis through hepatic nicotinic receptor signaling.
• Regulates short-term forgetting in C. elegans via levamisole-sensitive acetylcholine receptors.
• Is implicated in lung cancer biology through the acetylcholine receptor pathway.
• Provides targets for pharmacological modulation in anesthesia and neurological disorders.
• Surface density of receptors is dynamically controlled by AKT signaling and agrin.
• Offers a conserved model system for studying ligand-gated ion channel and GPCR signaling.
What Happens During acetylcholine receptor signaling pathway?
Ligand binding and receptor activation
In simple terms: Acetylcholine or a similar molecule docks onto the receptor and switches it on.
The pathway begins when a physiological ligand such as acetylcholine binds the orthosteric site of a nicotinic or muscarinic acetylcholine receptor. Nicotinic receptors are pentameric ligand-gated ion channels, and binding of two agonist molecules triggers a conformational change that opens a cation-selective pore. Muscarinic receptors are seven-transmembrane GPCRs that bind acetylcholine and activate heterotrimeric G proteins. This initial recognition event is the defining step of GO:0095500.
Ion flux and membrane depolarization
In simple terms: The open nicotinic receptor lets ions rush in, changing the cell's electrical charge.
For nicotinic receptors, opening of the ion pore permits Na+, K+ and Ca2+ flux across the membrane, producing depolarization and, at the neuromuscular junction, muscle contraction. Calcium entry can activate calcium-dependent enzymes and second messengers. This ionotropic arm is fast and directly couples ligand binding to electrical and biochemical changes.
G-protein coupling and second messenger generation
In simple terms: Muscarinic receptors activate helper proteins inside the cell that make signaling molecules.
Muscarinic acetylcholine receptors couple to Gq/11, Gi/o or Gs proteins, leading to activation of phospholipase C, adenylyl cyclase or ion channels. In humans, endogenous muscarinic signaling blunts α1-adrenergic vasoconstriction during higher-intensity handgrip exercise, showing that this arm modulates vascular tone in vivo. These second messenger cascades amplify the initial ligand-binding event.
Kinase cascades and transcriptional effects
In simple terms: The signal reaches kinases that change gene activity and cell behavior.
Downstream of receptor activation, kinase pathways such as JAK2/STAT3 and AKT are engaged. In postoperative ileus, electroacupuncture ameliorates intestinal inflammation by activating α7nAChR-mediated JAK2/STAT3 signaling. AKT signaling regulates agrin-mediated acetylcholine receptor surface density, linking receptor trafficking to kinase activity. These cascades convert a transient ligand signal into sustained changes in gene expression and cell physiology.
Cholinergic anti-inflammatory pathway
In simple terms: The receptor signal can calm inflammation through a dedicated anti-inflammatory route.
The α7 nicotinic acetylcholine receptor, together with the chaperone RIC-3, participates in the cholinergic anti-inflammatory pathway that suppresses cytokine production. This arm is important in sepsis, inflammatory bowel disease and postoperative ileus models. It illustrates how GO:0095500 extends beyond neurotransmission into immune regulation.
Receptor trafficking and surface density control
In simple terms: Cells control how many receptors sit on the surface, tuning the signal strength.
The number of acetylcholine receptors at the cell surface is dynamically regulated. Agrin promotes receptor clustering at the neuromuscular junction, and AKT signaling regulates agrin-mediated acetylcholine receptor surface density. This trafficking step determines the sensitivity of the cell to acetylcholine and is a key node for plasticity and disease.
Key Genes Involved in GO:0095500 acetylcholine receptor signaling pathway
The following genes and proteins are central to acetylcholine receptor signaling pathway (GO:0095500) and are frequently manipulated in research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHRNA7 | Encodes α7 nicotinic receptor subunit; mediates cholinergic anti-inflammatory signaling | Target for inflammation and sepsis studies |
| CHRNA1 | Nicotinic receptor α1 subunit at neuromuscular junction | Myasthenia gravis and neuromuscular transmission models |
| CHRNB1 | Nicotinic receptor β1 subunit; forms pentameric channel with α subunits | Receptor assembly and ion flux studies |
| CHRND | Nicotinic receptor δ subunit; contributes to ligand-binding site | Congenital myasthenic syndrome models |
| CHRNE | Nicotinic receptor ε subunit; adult neuromuscular junction | Receptor subunit switching studies |
| CHRM1 | Muscarinic M1 receptor; Gq-coupled | Vascular and cognitive signaling studies |
| CHRM2 | Muscarinic M2 receptor; Gi/o-coupled | Cardiac and smooth muscle studies |
| CHRM3 | Muscarinic M3 receptor; Gq-coupled | Smooth muscle contraction and secretion |
| RIC3 | Chaperone for α7 nAChR assembly and function | Cholinergic anti-inflammatory pathway studies |
| JAK2 | Kinase downstream of α7nAChR in JAK2/STAT3 signaling | Intestinal inflammation models |
| STAT3 | Transcription factor activated by JAK2 downstream of α7nAChR | Postoperative ileus and inflammation studies |
| AKT1 | Kinase regulating agrin-mediated receptor surface density | Receptor trafficking studies |
| AGRN | Agrin; promotes acetylcholine receptor clustering | Neuromuscular junction formation models |
| LEV-10 | C. elegans levamisole-sensitive receptor subunit | Short-term forgetting studies |
| UNC-29 | C. elegans nicotinic receptor subunit | Invertebrate learning and memory models |
| ACHE | Acetylcholinesterase; terminates acetylcholine signal | Pharmacological and toxicological studies |
| CHAT | Choline acetyltransferase; synthesizes acetylcholine | Cholinergic neuron studies |
How Is acetylcholine receptor signaling pathway Regulated?
Acetylcholine receptor signaling is regulated at multiple levels. Receptor surface density is controlled by agrin and AKT signaling, which determine how many receptors are available for ligand binding. The chaperone RIC-3 regulates assembly and functional expression of α7 nicotinic receptors, thereby tuning the cholinergic anti-inflammatory pathway. Downstream, JAK2/STAT3 and AKT cascades provide feedback and feedforward control of receptor signaling. In humans, endogenous muscarinic receptor signaling dynamically modulates α1-adrenergic vasoconstriction during exercise, showing physiological regulation of the pathway in vivo. Acetylcholinesterase terminates the signal by hydrolyzing acetylcholine, and its activity is a key regulatory checkpoint.
acetylcholine receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CHRNA7 | Cholinergic anti-inflammatory pathway; inflammation | Knockout mice and macrophage assays |
| JAK2 | Postoperative ileus; intestinal inflammation | Conditional knockout and electroacupuncture models |
| CHRNB1 | Neuromuscular transmission disorders | Point-mutation knock-in in muscle cells |
| CHRM3 | Smooth muscle and vascular tone | Overexpression in vascular smooth muscle cells |
| AKT1 | Receptor surface density regulation | Knockout and phospho-mutant knock-in |
Acetylcholine receptor signaling in lung cancer
The acetylcholine receptor pathway has been implicated in lung cancer biology, with nicotinic and muscarinic receptors influencing proliferation and survival of lung cancer cells. This has motivated research into receptor antagonists and subunit-specific targeting as potential therapeutic strategies.
Metabolic dysfunction-associated steatohepatitis
Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis. This finding links hepatic cholinergic signaling to lipid metabolism and inflammation, suggesting that receptor agonists or modulators could be explored for metabolic liver disease.
Inflammation and postoperative ileus
Activation of α7nAChR-mediated JAK2/STAT3 signaling ameliorates intestinal inflammation in postoperative ileus. The cholinergic anti-inflammatory pathway, involving α7nAChR and RIC-3, is therefore a therapeutic target for inflammatory conditions.
Neurological and cognitive disorders
Acetylcholine receptor signaling is essential for memory and learning. In C. elegans, levamisole-sensitive acetylcholine receptors regulate short-term forgetting, providing a conserved model for cognitive studies. In humans, muscarinic signaling modulates vascular responses during exercise, and receptor dysfunction is relevant to autonomic and neurological disorders.
From acetylcholine receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of α7nAChR abolish cholinergic anti-inflammatory signaling? | CHRNA7 knockout cell line or mouse |
| Does a specific receptor subunit mutation alter ion flux? | Point-mutation knock-in of CHRNB1 or CHRND |
| Does tagging the receptor reveal trafficking dynamics? | Tagged knock-in of CHRNA7 or CHRM3 |
| Does overexpression of RIC-3 enhance α7nAChR function? | Overexpression cell model |
| Does AKT regulate agrin-mediated receptor clustering? | AKT1 knockout and rescue |
| Does muscarinic signaling modulate vasoconstriction? | Muscarinic receptor overexpression in vascular cells |
How to Study the acetylcholine receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion channel opening and current | Nicotinic receptor function |
| Calcium imaging | Intracellular Ca2+ flux | Receptor activation and downstream signaling |
| Western blot (phospho-JAK2/STAT3) | Kinase activation | α7nAChR-JAK2/STAT3 studies |
| Western blot (phospho-AKT) | AKT pathway activity | Agrin-mediated receptor density |
| Biotinylation surface assay | Receptor surface density | Trafficking and clustering studies |
| C. elegans forgetting assay | Short-term memory retention | Levamisole-sensitive receptor genetics |
| Human handgrip exercise model | Vascular conductance and vasoconstriction | Muscarinic modulation in vivo |
| Immunohistochemistry | Receptor localization in tissue | Neuromuscular junction and liver studies |
Electrophysiology and calcium imaging
Patch-clamp electrophysiology and calcium imaging measure ion flux through nicotinic receptors and downstream calcium signals, directly reporting receptor activation. These methods are used to test subunit mutations and pharmacological modulators.
Phospho-protein and kinase assays
Western blotting for phospho-JAK2, phospho-STAT3 and phospho-AKT quantifies downstream kinase activation after receptor stimulation. These assays are standard for linking receptor binding to intracellular cascades.
Receptor surface density and trafficking assays
Biotinylation, fluorescence imaging and tagged-receptor knock-in models measure acetylcholine receptor surface density and clustering, as used to study agrin and AKT regulation.
Genetic and behavioral models
C. elegans levamisole-sensitive receptor mutants and short-term forgetting assays provide a conserved genetic system for studying acetylcholine receptor signaling in behavior. Mouse models of inflammation and exercise physiology test the pathway in vivo.
How CRISPR Can Be Used to Study GO:0095500 acetylcholine receptor signaling pathway
Knockout
CRISPR knockout of CHRNA7, JAK2 or STAT3 can test whether these genes are required for acetylcholine receptor signaling in inflammation and metabolism. Knockout cell lines provide clean backgrounds for receptor pharmacology and downstream assays.
Point Mutation
Point-mutation knock-in of receptor subunits such as CHRNB1 or CHRND can model congenital myasthenic syndromes and dissect ligand-binding versus gating defects. Point mutations in AKT1 can test phosphorylation-dependent regulation of receptor surface density.
Knock-in
Tagged knock-in of CHRNA7 or CHRM3 with fluorescent or epitope tags enables real-time tracking of receptor trafficking and surface density in live cells. Knock-in of reporter cassettes can also monitor pathway activity.
Overexpression
Overexpression of RIC-3 or muscarinic receptors can enhance pathway activity and reveal gain-of-function phenotypes in inflammation or vascular tone. Overexpression models are useful for testing receptor agonists and antagonists.
How EDITGENE Supports acetylcholine receptor signaling pathway Research
Researchers studying acetylcholine receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, inflammation, metabolism or cognition. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly.
Contact EDITGENE today to design your custom CRISPR model for acetylcholine receptor signaling pathway research.
Frequently Asked Questions About acetylcholine receptor signaling pathway
What is GO:0095500 acetylcholine receptor signaling pathway?
GO:0095500 is the biological process describing the molecular signals generated when an acetylcholine receptor binds a physiological ligand such as acetylcholine.
What genes are involved in acetylcholine receptor signaling pathway?
Key genes include CHRNA7, CHRNA1, CHRNB1, CHRND, CHRNE, CHRM1, CHRM2, CHRM3, RIC3, JAK2, STAT3, AKT1, AGRN and ACHE.
What are the two main types of acetylcholine receptors?
Nicotinic acetylcholine receptors are ligand-gated ion channels, while muscarinic acetylcholine receptors are G-protein-coupled receptors.
How does acetylcholine receptor signaling cause inflammation control?
α7nAChR activates JAK2/STAT3 signaling and the cholinergic anti-inflammatory pathway, reducing cytokine production.
Is acetylcholine receptor signaling involved in cancer?
Yes, the acetylcholine receptor pathway has been implicated in lung cancer biology.
What diseases are linked to acetylcholine receptor signaling?
Links include lung cancer, metabolic dysfunction-associated steatohepatitis, postoperative ileus and neuromuscular disorders.
How is acetylcholine receptor surface density regulated?
Agrin promotes receptor clustering, and AKT signaling regulates agrin-mediated acetylcholine receptor surface density.
What model organisms are used to study acetylcholine receptor signaling?
C. elegans is used for levamisole-sensitive receptor studies of short-term forgetting, and mice are used for inflammation and metabolic studies.
What methods measure acetylcholine receptor signaling?
Patch-clamp electrophysiology, calcium imaging, phospho-kinase Western blots, surface biotinylation and behavioral assays are commonly used.
How can CRISPR help study acetylcholine receptor signaling?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of receptor subunits and downstream kinases.
Conclusion
GO:0095500 acetylcholine receptor signaling pathway is a fundamental biological process that converts acetylcholine binding into ion flux, G-protein signaling and kinase cascades. Its roles span neurotransmission, inflammation, metabolism, vascular tone and cognition, with disease links to lung cancer, steatohepatitis and neuromuscular disorders. CRISPR-based models and pathway screening provide powerful tools to dissect these mechanisms and identify therapeutic targets.
References
- 1. Yang NN et al.. 2021. Electroacupuncture ameliorates intestinal inflammation by activating α7nAChR-mediated JAK2/STAT3 signaling pathway in postoperative ileus.. Theranostics 11(9):4078-4089 PMID: 33754049
- 2. Jun H et al.. 2024. Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis.. PLoS Biol 22(7):e3002728 PMID: 39028754
- 3. Dreyer F. 1982. Acetylcholine receptor.. Br J Anaesth 54(2):115-30 PMID: 6277353
- 4. Thunnissen FB. 2009. Acetylcholine receptor pathway and lung cancer.. J Thorac Oncol 4(8):943-6 PMID: 19633471
- 5. Jaiswal N et al.. 2026. AKT Signaling Regulates Agrin-Mediated Acetylcholine Receptor Surface Density.. Medicina (Kaunas) 62(3) PMID: 41901538
- 6. Niu S et al.. 2022. The signaling pathway of levamisole-sensitive-acetylcholine receptors involved in short-term forgetting of Caenorhabditis elegans.. Mol Genet Genomics 297(4):1027-1038 PMID: 35585325
- 7. Terwoord JD et al.. 2025. Endogenous muscarinic acetylcholine receptor signaling blunts α(1)-adrenergic vasoconstriction during higher-intensity handgrip exercise in humans.. Am J Physiol Regul Integr Comp Physiol 328(6):R619-R627 PMID: 40235317
- 8. Treinin M et al.. 2017. Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway.. Cent Nerv Syst Agents Med Chem 17(2):90-99 PMID: 27573666
